Opinion: Don’t Ban the Use of CRISPR in Embryos
John D. Loike | Nov 29, 2018
Despite a premature and ethically sketchy claim of genome editing in twin girls, an outright prohibition could blunt promising, responsible progress.
CRISPR Scientists Slam Methods Used on Gene-Edited Babies
CRISPR Scientists Slam Methods Used on Gene-Edited Babies
Since He Jiankui presented his results at last week’s gene editing summit, researchers have raised concerns about his protocol, calling the procedure “amateurish” and “unconscionable.”
Since He Jiankui presented his results at last week’s gene editing summit, researchers have raised concerns about his protocol, calling the procedure “amateurish” and “unconscionable.”
Second CRISPR-Modified Pregnancy May Be Underway
Ashley P. Taylor | Nov 28, 2018
He Jiankui, who reportedly edited the genomes of two babies already, broke the news at a conference in Hong Kong.
Rice University Professor Helped Generate CRISPR’d Babies
Ashley P. Taylor | Nov 27, 2018
The college has opened an investigation into Michael Deem’s involvement.
Claim of First Gene-Edited Babies Triggers Investigation
Catherine Offord | Nov 26, 2018
He Jiankui says he has successfully used CRISPR-Cas9 to tweak the genes of twins born earlier this month. Some independent experts are dubious.
Study: Gene Drive Wipes Out Lab Mosquitoes
Ashley Yeager | Sep 24, 2018
No females were produced after eight generations, causing the population to collapse.
Gene-Edited Skin Patch Prevents Cocaine Overdose in Mice
Shawna Williams | Sep 17, 2018
With a built-in supply of a powerful cocaine-chomping enzyme, the transplant might also curb addiction.
Federal Court Sides with Broad in CRISPR Patent Dispute
Jef Akst | Sep 10, 2018
The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.
Anti-CRISPR Proteins Found that Block Cas12a Nuclease
Ashley Yeager | Sep 6, 2018
Using bioinformatics, two teams of scientists identified inhibitory proteins for Cas9’s relative.
Early Results of First In Vivo Gene-Editing Trial Encouraging
Kerry Grens | Sep 5, 2018
Two patients who received Sangamo’s zinc finger–based treatment for Hunter syndrome have lower biomarkers of the condition, but no signs of new enzyme production.